HSIC Stock Analysis: Buy, Sell, or Hold?
HSIC - Henry Schein Inc
$75.48
1.14 (1.53%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
23d
Get Alerted When HSIC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HSIC shows positive signals but monitor for confirmation. Market pricing in 0.9% decline. Moderate conviction.
💡 BUY OPPORTUNITY: HSIC shows positive signals but monitor for confirmation. Market pricing in 0.9% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$101.77
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$63.19
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSIC is currently trading at $75.48, which is considered fair relative to its 30-day fair value range of $76.25 to $78.49. The stock's valuation (Forward PE: 14.1) is in line with its historical norms (14.5). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This pessimistic expectation contrasts with the company's recent 7.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, HSIC is in a strong uptrend. The price is currently testing key support at $73.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSIC is in a strong uptrend. The price is currently testing key support at $73.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$76.25 -
$78.49
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.6%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($78.14)
Fair Price Analysis
30-Day Fair Range
$76.25 -
$78.49
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$73.59
Resistance Level
$80.10
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
14.07
Wall Street Target
$78.14
(+5.1%)
Revenue Growth (YoY)
5.2%
Earnings Growth (YoY)
7.7%
Profit Margin
3.0%
Valuation Discount vs History
-0.9% cheaper
PE vs Historical
14.1 vs 14.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.9%
(market-implied from PE analysis)
1-Year Target
$73.67
(-1%)
2-Year Target
$73.01
(-2%)
3-Year Target
$72.35
(-3%)
3-Yr Target (if PE normalizes)
(PE: 14→15)
$74.57
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 7.7%)
$147.16
(+98%)
Base:
(SPY PE: 14.1, Growth: 7.7%)
$92.84
(+25%)
Bear:
(PE: 12.0, Growth: 7.7%)
$78.92
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 23.68 | Current EPS (TTM): $3.17
Bull Case
$137.66
(+82%)
Analyst growth 66.7%, PE expands to 26.1
Base Case
$125.15
(+66%)
Market implied 66.7%, PE stable at 23.7
Bear Case
$51.05
(-32%)
Severe decline -20.0%, PE contracts to 20.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.1 to 14.5
Stabilization Target:
$76.62
(+3.1%)
PE Expansion Potential:
+3.1%
Last updated: January 31, 2026 11:42 AM ET
Data refreshes hourly during market hours. Next update: 12:42 PM
Data refreshes hourly during market hours. Next update: 12:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSIC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael T. McCaul
SELL
2025-08-21
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$942 | 60 HOLD |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$230 | 66 BUY |
|
COR
Cencora Inc. |
BUY
17 analysts |
$397 | 65 BUY |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 54 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced HSIC Option Strategies
Professional options setups generated by AI based on today's HSIC price and gamma walls.
